Developmental Research Program
Developmental Research Program
批准号:
9752979
负责人:
Robert M Prins
金额:
$7.21万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AddressAwardBrainCaliforniaCancer CenterCancer FamilyCitiesCollaborationsComprehensive Cancer CenterDataDevelopmentElectronic MailFacultyFosteringFundingFunding OpportunitiesGoalsHospital AdministrationInstitutesInstitutionInvestigationLettersLos AngelesMalignant neoplasm of brainMedical centerMedicineMissionMonitorOutcomePilot ProjectsRecommendationRequest for ApplicationsResearchResearch InstituteResearch PersonnelResearch Project GrantsScheduleScienceTimeTranslational ResearchUnited States Department of Veterans AffairsUniversitiesanticancer researchbasecareerhigh rewardhigh riskinnovationinterdisciplinary collaborationmeetingsneurosurgerynovelprogramsprospective
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DRP: Developmental Research Program
SUMMARY/ABSTRACT
The goal of the UCLA SPORE in Brain Cancer Developmental Research Program (DRP) is to foster the
exploration of innovative research ideas through the funding of pilot developmental research projects in the
field of brain cancer. This program will identify new, innovative projects for funding that will constantly renew
the vigor of our Brain SPORE research portfolio and add to, augment, or replace current major research
projects. The DRP represents a timely mechanism to expand discovery within the SPORE. Each year, three
highly innovative proposals will be selected for funding. Prospective developmental research projects will be
solicited through a request for applications (RFA) sent throughout the UCLA main campus and affiliated
institutions (i.e., LA BioMed/UCLA Harbor Medical Center, Charles Drew University of Medicine and Science,
West Los Angeles Veterans Administration Hospital, Southern California Kaiser Permanente, and Cedars-Sinai
Medical Center). We will also solicit proposals for our DRP through other institution-wide, state-wide, and
region-wide channels. This will include e-mail solicitations to all faculty at UCLA and other University of
California campuses (Berkeley, Davis, Irvine, Riverside, San Diego, Santa Barbara, and Santa Cruz), as well
as to researchers at Caltech and USC. We will also solicit applications through the major NCI-funded Cancer
Centers in Southern California (UCLA Jonsson Cancer Center, USC Norris Cancer Center, City of Hope
Cancer Center, UCI Chao Family Cancer Center, UCSD Moores Cancer Center, Sanford-Burnham Research
Institute, and the Salk Institute). Potential DRP investigators will be asked for a proposal, biosketch, and
letters of recommendation. Three awards of $50,000 each (totaling $150,000 per year) will be made annually
for the duration of the SPORE award. Funding will be made primarily for new and innovative ideas, but also to
initiate intra- and inter-SPORE collaborations. Faculty at all levels will be encouraged to apply, both those
beginning a research career, and established investigators who wish to re-direct their research into the field of
brain cancer. This should provide a broad base of applicants and new ideas, providing funding opportunities
for investigators from a variety of local and regional institutions. The DRP Selection Committee will meet and
select the most meritorious translational brain cancer research applications, with input from outside ad hoc
reviewers as necessary. Following scoring by the DRP Selection Committee, the Executive Committee (EC)
will meet to determine the funding line. The Internal Advisory Board (IAB) and External Advisory Board (EAB)
will review the funding decisions and progress of developmental projects at their regularly scheduled meetings.
The DRP will receive matching funds from the Jonsson Comprehensive Cancer Center (JCCC) and the UCLA
Department of Neurosurgery. Successful translational research projects may receive further funding in the
SPORE and replace unproductive funded major projects. The anticipated outcome of the DRP is to enlarge
the overall pool of brain cancer SPORE investigators at UCLA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neoadjuvant checkpoint blockade for recurrent glioblastoma
-
批准号:10343478
-
项目类别:
-
资助金额:$50.94万
-
财政年份:2022
-
负责人:Robert M Prins
-
依托单位:
Neoadjuvant checkpoint blockade for recurrent glioblastoma
-
批准号:10661485
-
项目类别:
-
资助金额:$48.36万
-
财政年份:2022
-
负责人:Robert M Prins
-
依托单位:
Identification and cloning of neoantigen-specific T cells for GBM immunotherapy
-
批准号:9903258
-
项目类别:
-
资助金额:$41.07万
-
财政年份:2019
-
负责人:Robert M Prins
-
依托单位:
Identification and cloning of neoantigen-specific T cells for GBM immunotherapy
-
批准号:10599231
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2019
-
负责人:Robert M Prins
-
依托单位:
Identification and cloning of neoantigen-specific T cells for GBM immunotherapy
-
批准号:10375387
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2019
-
负责人:Robert M Prins
-
依托单位:
Developmental Research Program
-
批准号:9983051
-
项目类别:
-
资助金额:$7.37万
-
财政年份:2017
-
负责人:Robert M Prins
-
依托单位:
Project 1: Targeting immunotherapy-induced resistance with DC vaccination and PD-1/CSF-1R inhibition
-
批准号:10673749
-
项目类别:
-
资助金额:$37.84万
-
财政年份:2017
-
负责人:Robert M Prins
-
依托单位:
Developmental Research Program
-
批准号:10225554
-
项目类别:
-
资助金额:$7.21万
-
财政年份:2017
-
负责人:Robert M Prins
-
依托单位:
Developmental Research Program
-
批准号:10673782
-
项目类别:
-
资助金额:$11.81万
-
财政年份:2017
-
负责人:Robert M Prins
-
依托单位:
Optimizing Induction Conditions for Immunotherapeutic CTL
-
批准号:8704325
-
项目类别:
-
资助金额:$38.26万
-
财政年份:2010
-
负责人:Robert M Prins
-
依托单位:
CNS Anti-tumor immunity induced by dendritic cell vaccination and TLR agonists
-
批准号:7754039
-
项目类别:
-
资助金额:$23.48万
-
财政年份:2007
-
负责人:Robert M Prins
-
依托单位:
CNS Anti-tumor immunity induced by dendritic cell vaccination and TLR agonists
-
批准号:7258092
-
项目类别:
-
资助金额:$23.48万
-
财政年份:2007
-
负责人:Robert M Prins
-
依托单位:
CNS Anti-tumor immunity induced by dendritic cell vaccination and TLR agonists
-
批准号:7371862
-
项目类别:
-
资助金额:$23.48万
-
财政年份:2007
-
负责人:Robert M Prins
-
依托单位:
CNS Anti-tumor immunity induced by dendritic cell vaccination and TLR agonists
-
批准号:7540375
-
项目类别:
-
资助金额:$23.48万
-
财政年份:2007
-
负责人:Robert M Prins
-
依托单位:
Immune targeting of melanoma-associated antigens in glioma
-
批准号:7100552
-
项目类别:
-
资助金额:$11.73万
-
财政年份:2006
-
负责人:Robert M Prins
-
依托单位:
Immune targeting of melanoma-associated antigens in glioma
-
批准号:7455314
-
项目类别:
-
资助金额:$14.88万
-
财政年份:2006
-
负责人:Robert M Prins
-
依托单位:
Immune targeting of melanoma-associated antigens in glioma
-
批准号:7842484
-
项目类别:
-
资助金额:$14.88万
-
财政年份:2006
-
负责人:Robert M Prins
-
依托单位:
Immune targeting of melanoma-associated antigens in glioma
-
批准号:7643480
-
项目类别:
-
资助金额:$14.88万
-
财政年份:2006
-
负责人:Robert M Prins
-
依托单位:
Immune targeting of melanoma-associated antigens in glioma
-
批准号:7252008
-
项目类别:
-
资助金额:$14.15万
-
财政年份:2006
-
负责人:Robert M Prins
-
依托单位:
Project 1: Active immunotherapy combined with checkpoint modulation for glioblastoma
-
批准号:9357417
-
项目类别:
-
资助金额:$35.2万
-
财政年份:--
-
负责人:Robert M Prins
-
依托单位:
海外基金